Policies and Instructions on Abstract Submission
Open to all Orthopaedic Surgeons, Fellows, and Residents
Irish-American Orthopaedic Society (IAOS)
2019 Orthopaedic Conference
September 6-8, 2019
Sea Crest Beach Hotel
Cape Cod, Massachusetts
Submission Deadline: May 17, 2019
(Please read all of the instructions below before clicking the link at the bottom of this page to submit Abstract)
Policies Governing Accepted Submissions:
Abstracts must be submitted online by May 17, 2019 in order to be eligible for review by the Program Committee.
Submission of a corrected abstract is not allowed after May 17, 2019, unless otherwise specified.
Once an abstract is accepted, additional authors cannot be added.
An orthopaedic surgeon, fellow, resident, or a member of IAOS must be listed as one of the authors.
Acceptance or rejection letters and all future correspondence will be emailed to the Primary Author listed on the Abstract. Notification of acceptance will be sent to the email address provided on the abstract. Presenter should respond back to the Program Committee by the requested date listed on their acceptance letter. The paper should be original, unpublished work.
All co-authors must complete a disclosure form upon acceptance of the Abstract.
The IAOS reserves the right to withdraw a presentation at any time.
Instructions to complete abstract submission:
TITLE: Make the title brief and clearly indicate the nature of the study/procedure.
CONTENT: The abstract must include four parts:
- INTRODUCTION should clearly state the problem and the purpose of the study;
- METHODS should provide a description of what was actually done;
- RESULTS should contain the findings of the study;
- DISCUSSION/CONCLUSION should be based upon the findings and relate to the stated purpose of the study and existing knowledge. Provide specific details about your research/study.
LENGTH: The abstract should be typed in English and should represent a 5-7 minute long presentation.
STYLE: DO NOT include company names, titles, appointments, or addresses in the abstract. DO NOT use subtitles. Standard abbreviations may be used, when necessary. Do not cite references. Omit P values. No reference is to be made in your text as to authors, institutions, clinics, pharmaceutical companies, or specific manufacturers. Please check your work prior to submission. The IAOS is not responsible for proofreading or accuracy.
DRUG NAMES: Non-proprietary (generic) names of drugs are required and should be written in lower case. Proprietary names are capitalized.
SUBMISSIONS: An electronic form of your abstract should be attached to your email submission. The abstract submission deadline for IAOS’s 2019 Conference is May 17, 2019.
NOTIFICATION OF ACCEPTANCE: The IAOS Program Committee will review Abstracts. You will be notified of acceptance by email. The IAOS reserves the right to withdraw a paper at any time.
REGISTRATION FEES: All presenters are required to register for the meeting and pay the registration fee. The Moderator/Presenter or Resident/Fellow registration fee must be paid by all other presenters.
MANUSCRIPT: The paper should be an original, unpublished work. Papers that have been previously published are ineligible. Papers that have been submitted for publication but will remain unpublished prior to the date of the Annual Meeting are eligible. If a paper is accepted but is subsequently found to have been published before the Annual Meeting, the IAOS Board has the right to withdraw the paper.
Each Podium presentation should be approximately 5-7 minutes in length. Personal laptops will not be used for presentations. Presentations must be sent electronically 48 hours prior to presentation.